Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1,4 USD | +2,19% | -4,76% | -11,95% |
01/05 | CYCLO THERAPEUTICS, INC. : HC Wainwright bevestigt koopadvies | ZM |
18/03 | Cyclo Therapeutics, Inc. Rapporteert winstresultaten voor het volledige jaar dat eindigde op 31 december 2023 | CI |
Vakgebied
Aantal werknemers: 8
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Cyclodextrin-based Products
100,0
%
| 1 | 100,0 % | 1 | 100,0 % | -21,76% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 1 | 100,0 % | 1 | 100,0 % | -21,76% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Charles Strattan
FOU | Founder | 78 | 09-08-90 |
Scott Fine
CEO | Chief Executive Officer | 67 | 01-02-14 |
Joshua Fine
DFI | Director of Finance/CFO | 42 | 01-01-14 |
Jeffrey Tate
COO | Chief Operating Officer | 66 | 17-08-10 |
Michael Lisjak
LAW | General Counsel | 50 | 08-07-19 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Scott Fine
CEO | Chief Executive Officer | 67 | 01-02-14 |
Charles Strattan
FOU | Founder | 78 | 09-08-90 |
William Shanahan
BRD | Director/Board Member | 84 | 07-06-16 |
Chairman | 58 | 01-02-14 | |
Vivien Wong
BRD | Director/Board Member | 67 | 17-08-23 |
Shawn Cross
BRD | Director/Board Member | 56 | 27/12 |
Jeffrey Tate
COO | Chief Operating Officer | 66 | 17-08-10 |
F. Ostronic
BRD | Director/Board Member | 68 | 09-04-14 |
Randall Toig
BRD | Director/Board Member | 73 | 20-03-18 |
William Conkling
BRD | Director/Board Member | 53 | 02-05-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 28 615 740 | 17 378 910 ( 60,73 %) | 0 | 60,73 % |
Bedrijfsgegevens
Cyclo Therapeutics, Inc.
6714 NW 16th Street Suite B
32653, Gainesville
+
http://www.cyclotherapeutics.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-11,95% | 40,2 mln. | |
+32,09% | 693 mld. | |
+29,39% | 584 mld. | |
-1,34% | 372 mld. | |
+20,34% | 332 mld. | |
+7,39% | 294 mld. | |
+13,68% | 239 mld. | |
-3,03% | 211 mld. | |
+10,02% | 210 mld. | |
+8,49% | 168 mld. |
- Beurs
- Aandelen
- Koers CYTH
- Onderneming Cyclo Therapeutics, Inc.